Maher M Akla*
 
*Correspondence: Maher M Akla, Department of Chemistry, Mansoura University, Mansoura, Egypt,
Tel: 201020432031, Email: maherakl555@gmail.com

Author info »

Introduction

Type 2 diabetes is a chronic disease characterized by insulin resistance, leading to hyperglycemia and a range of complications. Lifestyle interventions, including exercise, healthy eating, and weight loss, are the first-line treatments for type 2 diabetes. However, these interventions may not always be sufficient, and medication is often required to manage blood glucose levels. L-carnitine is an amino acid derivative that has been proposed as a potential treatment for insulin resistance and type 2 diabetes.

L-carnitine and insulin resistance

L-carnitine plays a crucial role in fatty acid metabolism, facilitating the transport of fatty acids into the mitochondria for energy production. Studies have shown that L-carnitine supplementation can improve insulin sensitivity and glucose uptake in skeletal muscle cells [1]. L-carnitine has also been shown to improve insulin resistance in animal models of type 2 diabetes [2].

Description

Clinical studies on L-carnation and type 2 diabetes

Several clinical studies have investigated the potential of L-carnitine in the treatment of type 2 diabetes. A randomized controlled trial involving 60 patients with type 2 diabetes found that L-carnitine supplementation improved insulin sensitivity and reduced oxidative stress markers [3]. Another study involving 60 patients with type 2 diabetes found that L-carnitine supplementation reduced fasting blood glucose levels and improved lipid profiles [4]. A meta-analysis of 9 randomized controlled trials found that L-carnitine supplementation significantly improved glycemic control and lipid profiles in patients with type 2 diabetes [5].

Mechanisms of action

The mechanisms of action of L-carnitine in the treatment of type 2 diabetes are not fully understood. However, it is believed that L-carnitine may improve insulin sensitivity and glucose uptake by enhancing mitochondrial function and reducing oxidative stress. L-carnitine may also improve lipid metabolism and reduce inflammation, which are both implicated in the development of insulin resistance and type 2 diabetes.

Conclusion

L-carnitine has shown promise as a potential treatment for insulin resistance and type 2 diabetes. Clinical studies have demonstrated its efficacy in improving glycemic control and lipid profiles in patients with type 2 diabetes. The mechanisms of action of L-carnitine in the treatment of type 2 diabetes are not fully understood, but it is believed to improve mitochondrial function, reduce oxidative stress, and improve lipid metabolism. Further research is needed to fully elucidate the potential of L-carnitine in the treatment of insulin resistance and type 2 diabetes.

References

Author Info

1Department of Chemistry, Mansoura University, Mansoura, Egypt
 

Received: 17-Mar-2023, Manuscript No. JDCM-23-92116; Editor assigned: 20-Mar-2023, Pre QC No. JDCM-23-92116 (PQ); Reviewed: 04-Apr-2023, QC No. JDCM-23-92116; Revised: 07-Jun-2023, Rev Manuscript No. JDCM-23-92116 (R); Published: 16-Jun-2023, DOI: 10.37421/2475-3211.2023.8.209

Citation: Akla, Maher M. "L-Carnation May Improve Insulin Sensitivity and Glucose Uptake by Enhancing Mitochondrial Function and Reducing Oxidative Stress." J Diabetic Complications Med 8 (2023): 209.

Copyright: © 2023 Akla MM. This is an open-access article distributed under the terms of the creative commons attribution license which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.